Amgen Inc. buy UBS Group AG
Start price
26.01.26
/
50%
€293.05
Target price
26.01.27
-
Performance (%)
2.16%
Price
09:26
€296.85
Summary
This prediction is currently active. The BUY prediction by UBS_Group_AG shows slight gains of 2.16%. Dividends of €2.52 are taken into consideration when calculating the performance. This prediction currently runs until 26.01.27. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Amgen Inc. | -1.409% | -1.409% |
| iShares Core DAX® | 3.023% | 2.202% |
| iShares Nasdaq 100 | 3.561% | 1.325% |
| iShares Nikkei 225® | 6.618% | 5.707% |
| iShares S&P 500 | 2.635% | 1.008% |
Comments by UBS_Group_AG for this prediction
In the thread Amgen Inc. diskutieren
Amgen (NASDAQ:AMGN) had its "buy" rating reaffirmed by analysts at UBS Group AG.
Ratings data for AMGN provided by MarketBeat